drugset / Trial / NCT07110441
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy Subjects
Timeline
- Start
- 2025-08-26
- Primary completion
- 2025-12-01
- Completion
- 2025-12-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitazoxanide | Other / unclassified | 300 mg | — |
| Subject | Nitazoxanide | Other / unclassified | 600 mg | — |
| Subject | Nitazoxanide | Other / unclassified | 900 mg | — |
| Subject | Nitazoxanide | Other / unclassified | 1200 mg | — |